Marrone Bio Innovations Inc (MBII) Growth Rates Comparisons to Agricultural Production Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Marrone Bio Innovations Inc   (NASDAQ: MBII)
 

Marrone Bio Innovations Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MBII Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 0.53 % 32.18 % 13.62 % 14.5 %
Q / Q Revenue Growth (Q1 MRQ) 2.58 % 2 % -3.93 % -1.48 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 11.59 % 38.07 % 15.51 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 0.13 % 6.33 % 2.88 % 3 %
Revenue 5 Year Average Growth 25.84 % 9.04 % 9.75 % 12.72 %


MBII's Growth Comparisons in I. Quarter 2022




Although the Agricultural Production industry saw advancing Revenue by 32.18%, Marrone Bio Innovations Inc announced 0.53% year on year sales decline in the first quarter 2022, to $ 11 millions, and underperformed the 13.62% Revenue improvement in the Consumer Non Cyclical sector. Comparing the first quarter, sales Marrone Bio Innovations Inc was trailing overall market not just Agricultural Production industry.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 2.58% . On the yearly basis, average annual sales growth for Marrone Bio Innovations Inc is 25.84%, while S & P 500's including only Businesses with the first quarter 2022 earnings, average annual sales growth is 12.72% over the past five years.


Growth Rates of MBII's Income in the first quarter 2022


MBII Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 94.76 % 28.7 % 14.73 %
Sequential Operating Income Change (Q1 MRQ) - 70.63 % 26.34 % -12.7 %
Y / Y Operating Income Growth (Q1 TTM) - 91.33 % 20.34 % 59.76 %
Sequential Operating Income Growth (Q1 TTM) - 23.95 % 6.68 % 2.49 %
Operating Income 5 Year Avg. Change - 29.1 % 12.93 % 16.54 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - 7.87 % 32.58 % 12.59 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -31.84 % 10.95 % 3.2 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 32.52 % 23.69 % 63.82 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 3.89 % 7.95 % 0.34 %
Income from Cont. Ops. 5 Year Avg. Change - 31.18 % 11.43 % 23.18 %

MBII Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - 6.91 % 32.48 % 13.8 %
Q / Q Net Income Growth (Q1 MRQ) - -11.21 % 14.96 % 3.68 %
Y / Y Net Income Change (Q1 TTM) - 29.85 % 25.64 % 67.8 %
Sequential Net Income Change (Q1 TTM) - 4.11 % 8.05 % 0.66 %
Net Income 5 Year Avg. Growth - 30.83 % 10.98 % 22.5 %

MBII's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - 1.12 % 32.58 % 12.59 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -32.51 % 10.95 % 3.2 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - -17.97 % - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - -5.5 % - 6640.43 %
EPS from Cont. Ops. 5 Year Avg. Growth - 13.61 % 11.43 % 23.18 %



MBII EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - 0.22 % 32.48 % 23.18 %
Q / Q EPS Net Growth (Q1 MRQ) - -12.08 % 14.96 % 3.68 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - -53.31 % - 40036.37 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - -47.74 % - 55.38 %
EPS Net 5 Year Avg. Change - 30.83 % 10.98 % 22.5 %



Marrone Bio Innovations Inc reported bottom-line of $ -0.04 in the first quarter, compare to $ -0.02 in the same quarter a year ago. Agricultural Production industry grew by 0.22%, while Consumer Non Cyclical sector increased by 32.48%, and overall market improved by 13.8%.

Comparing company's EPS to the fourth quarter results, income per share were higher by 2.58% . On the yearly basis, average annual income per share growth for Marrone Bio Innovations Inc is 25.84%, while S & P 500's including only the businesses with the first quarter 2022 Results, average annual income per share growth is 22.5% over the past five years.

MBII Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - - -61.53 % -0.56 %
Sequential Free Cash Flow Change (Q1 MRQ) - - -89.15 % -42.06 %
Y / Y Free Cash Flow Change (Q1 TTM) - - -10.37 % 35.72 %
Sequential Free Cash Flow Change (Q1 TTM) - -49.93 % -11.61 % -3.7 %
Free Cash Flow 5 Year Avg. Change - 41.03 % 24.29 % 35.41 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - 5.21 % - -
Sequential Net Cash Flow Change (Q1 MRQ) - 1325.59 % - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -85.17 %
Sequential Net Cash Flow Change (Q1 TTM) - -10.17 % - -60.83 %
Net Cash Flow 5 Year Avg. Change - 97.7 % 2.53 % 114.8 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 66.39 % 11.93 % 18.68 % 11.66 %
Sequential Capital Expenditures Change (Q1 MRQ) 5.32 % -40.45 % -32.85 % -22.93 %
Y / Y Capital Expenditures Change (Q1 TTM) 115.84 % 26.74 % 33.83 % 20.71 %
Sequential Capital Expenditures Change (Q1 TTM) 7.23 % 1.91 % 2.54 % 2.76 %
Capital Expenditures 5 Year Avg. Change - 0.1 % 10.86 % 12.23 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.